Impact of a dedicated infusion clinic for acute management of adults with sickle cell XXXX crisis.

@entity1 @entity341 @entity3458 @entity158
Most adults with @entity3458 ( @entity3458 ) receive care for their acute @entity158 episodes in an @entity341 ( @entity341 ) setting. The purpose of this article is to describe the impact of opening a dedicated treatment center for adults with @entity3458 [ @entity3458 ( @entity3458 )] on @entity1 outcomes and on hospital discharges for @entity3458 . Descriptive data including demographics, time to first dose of narcotic, and @entity158 scores were collected on @entity1 presenting to the @entity3458 and @entity341 . Maryland hospital discharge data were obtained from the Maryland Health Services Cost Review Commission. Analyses were conducted using T tests,   (2) tests, and simple generalized estimating equation regression models accounting for the clustered nature of observations, as appropriate. There were 3,874 visits to the @entity3458 by 361 unique @entity1 ; 85% of those visits resulted in the @entity1 being sent home. During the same time period, there were 3,408 visits to the @entity341 by 558 unique @entity1 with @entity3458 . The overall admission rate from the @entity341 for these @entity1 was 35.9% but decreased significantly over the time period with a rate of 20% in December 2011. There was a significant decrease in readmissions over time for the entire Baltimore Metro area with the likelihood of readmission decreasing by 7% over time. The @entity3458 model provides adults with @entity3458 access to high quality care that decreases the need for hospital admission. Further research needs to be done to evaluate the cost effectiveness of this model.
